< Back to situations

[ORGANIZATION]

US FDA

Featured in 3 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [KR] [US] [JP]

South Korea AI chip volatility and semiconductor expansion

294 clusters · 707 sources · last updated

Latest: South Korean bond yields fall amid semiconductor volatility and AI concerns

The AI-memory surge and subsequent market volatility evolved through late 2026. Following a period of significant sell-offs, the KOSPI saw a massive single-day gain of roughly 18% on July 31, driven by Samsung Electronic

[QUIET] [BUSINESS] [US] [DK]

FDA review delay for Novo Nordisk hemophilia drug

2 clusters · 6 sources · last updated

Latest: Novo Nordisk Denecimig review extended by FDA

The U.S. Food and Drug Administration (FDA) has extended its review of Novo Nordisk’s experimental drug denecimig, a bispecific antibody intended to treat hemophilia A. Novo Nordisk reported that the delay is due to on

Also covered in